Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 3/20 | 0.37 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.34 |
| ▸ | TLR4 | O00206 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8771449 | 1.00 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL4798580 | 1.00 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL4798556 | 1.00 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL8961286 | 0.95 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL8146444 | 0.95 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL12032041 | 0.94 | SLC6A2 (0.36) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL10479865 | 0.94 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL10479867 | 0.94 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL9809556 | 0.92 | MAOB (0.40) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL21581480 | 0.92 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115981060-A | High-shielding-degree electric control dimming color-changing film and preparation method thereof | 珠海兴业新材料科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| EP-0502407-B1 | Nematic liquid-crystal composition for active matrix application | SHARP KK (JP) | 1996-02-07 | — | — | EP | claimed |
| CN-115981060-A | High-shielding-degree electric control dimming color-changing film and preparation method thereof | 珠海兴业新材料科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20210102122-A1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2021-04-08 | — | — | US | disclosed |
| US-9493704-B2 | Cycloheptane derivative and preparation method and use thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-11-15 | — | — | US | disclosed |
| US-9493704-B2 | Cycloheptane derivative and preparation method and use thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-11-15 | — | — | US | disclosed |
| US-20150252261-A1 | CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) | 2015-09-10 | — | — | US | disclosed |
| US-20150252261-A1 | CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) | 2015-09-10 | — | — | US | disclosed |
| US-7951577-B2 | Liquid crystals with reduced toxicity and applications thereof | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-05-31 | — | — | US | disclosed |
| US-7820251-B2 | Liquid crystal compound and liquid crystal display utilizing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-10-26 | — | — | US | disclosed |
| US-7820251-B2 | Liquid crystal compound and liquid crystal display utilizing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-10-26 | — | — | US | disclosed |
| WO-1991000898-A1 | SUPER-TWIST LIQUID CRYSTAL DISPLAY | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1991-01-24 | — | — | WO | disclosed |
| EP-0406468-A1 | Nematic-liquid-crystal composition for active matrix application | SHARP CORPORATION (JP) | 1991-01-09 | — | — | EP | disclosed |
| EP-0394419-A1 | MATRIX LIQUID CRYSTAL DISPLAY. | MERCK PATENT GMBH (DE) | 1990-10-31 | — | — | EP | disclosed |
| WO-1990004623-A1 | MATRIX LIQUID CRYSTAL DISPLAY | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-05-03 | — | — | WO | disclosed |
| EP-0365962-A1 | Matrix-type liquid-crystal display | MERCK PATENT GmbH (DE) | 1990-05-02 | — | — | EP | disclosed |
| US-4917819-A | Cyclohexane derivative and liquid crystal composition containing same | CHISSO CORPORATION (JP) | 1990-04-17 | — | — | US | disclosed |
| EP-0205998-B1 | CYCLOHEXANE DERIVATIVE AND LIQUID CRYSTAL COMPOSITION CONTAINING SAME | Chisso Corporation (JP) | 1990-02-28 | — | — | EP | disclosed |
| US-4797228-A | Cyclohexane derivative and liquid crystal composition containing same | CHISSO CORPORATION (JP) | 1989-01-10 | — | — | US | disclosed |
| EP-0205998-A1 | Cyclohexane derivative and liquid crystal composition containing same | Chisso Corporation (JP) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150252261-A1 | CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | DHPS, DHCR24, CCNT1 | SLC6A2 4251/4885SLC6A4 3548/4885SLC6A3 3818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.